An Open-Label, Phase 1b study to evaluate safety, tolerability and preliminary activity of the CTPS1 inhibitor STP938 in adult subjects with high risk essential thrombocythaemia who are resistant to or intolerant of hydroxycarbamide therapy (STP938-301)

Principal Investigator

Prof Adam Mead

Contact us

Email: Latephasehaematology@ouh.nhs.uk

IRAS number

1011011